ED AI Africa

Envisionit Deep AI, also known as EdAI Africa, is a pioneering medical technology company founded in 2019 that harnesses the power of artificial intelligence to transform diagnostic imaging across Africa and beyond. Founded by Dr. Jaishree Naidoo, a paediatric radiologist with over 20 years of experience, alongside Terence Naidu and Andrei Migatchev, the company was born from a deep understanding of the critical shortages in healthcare resources across Africa. With a mission to democratize access to diagnostic healthcare, Envisionit Deep AI develops innovative solutions that enable faster, more accurate, and more affordable medical imaging diagnosis, addressing the continent’s severe shortage of radiologists and diagnostic infrastructure.

The company’s flagship product, RADIFY, represents a breakthrough in AI-assisted radiology. This FDA-cleared and SAHPRA-approved platform uses deep learning algorithms to analyze chest X-rays, mammograms, and other medical imaging, capable of detecting over 25 different pathologies including tuberculosis, breast cancer, and pneumonia. RADIFY can process and prioritize over 2,000 X-rays per minute, dramatically reducing the time from imaging to diagnosis. During the COVID-19 pandemic, the platform proved invaluable at a 700-bed hospital in South Africa’s Northern Cape province, where it enabled continuous triage and diagnosis when the facility’s sole radiologist fell ill. Beyond RADIFY, the company has developed RATIFY, an independent AI assurance platform that provides real-time monitoring, validation, and governance of medical AI systems, ensuring compliance with EU and FDA standards and setting new benchmarks for safety and accountability in healthcare AI.

Envisionit Deep AI has achieved significant milestones and recognition on the global stage. The company secured $1.65 million in Series A funding from New GX Ventures SA and GIIG Africa Fund after winning the Southern Africa regional finale at the Global Startup Awards Africa. In 2025, it joined the prestigious Morgan Stanley Inclusive & Sustainable Ventures cohort and became the first African-founded company to receive FDA clearance for an AI medical device. Now headquartered in the UK while maintaining strong roots in South Africa, Envisionit Deep AI continues to expand its reach across Africa’s mining sector, hospitals, and radiology practices, while pursuing regulatory approvals in Europe and the United States. The company’s vision extends beyond Africa, aiming to set the global standard for independent monitoring and assurance of medical AI, ultimately reducing diagnostic errors and improving patient outcomes worldwide.